IBM's senior vice president, solutions portfolio and research. Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi it held earlier this year as uptake ...

So Apptio is a big play for us there ... For IBM partners, what’s your message to them and their customers with IBM’s sale of QRadar to Palo Alto Networks? As we look at our QRadar on-prem ...